Named Patient Programme – UK
MHRA Unlicensed Medicinal Products Notification FormStatutory28 days
Description & Eligibility
Allows UK physicians to prescribe unauthorized medicines to meet special patient needs. Request must be initiated by physician and approved by MHRA on case-by-case basis.
Eligibility Criteria
Patients with unmet medical needs where licensed alternatives are unsuitable
Legal Reference / Source
UK Human Medicines Regulations 2012, Regulation 167
Named Patient Programme – UK
| Approval Form | MHRA Unlicensed Medicinal Products Notification Form |
| Timeline | 28 days |
| Legal Status | Statutory |
| Source Ref. | UK Human Medicines Regulations 2012, Regulation 167 |
| Countries | 0 countries |
Compliance Check
Legal Review3/21/2026
Global ValidityVerified